Organization
Centre hospitalier de l'Université de Montréal
27 clinical trials
6 abstracts
Clinical trial
Addition of High Dose Stimulant and Engagement-focused Contingency Management (CM), Alone and in Combination, to Treatment as Usual (TAU) for the Management of Methamphetamine (MA) Use Disorder (ASCME): a Canadian Multi-centre, RCTStatus: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
Randomized Phase II Study of Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide ProgressionStatus: Active (not recruiting), Estimated PCD: 2024-07-30
Clinical trial
A Randomized Single-blinded Clinical Trial of the Efficacy of Intra-articular Infiltration of Cingal (Sodium Hyaluronate/Triamcinolone) Versus Cortisone (Triamcinolone) in Patients With Osteoarthritis of the Shoulder.Status: Recruiting, Estimated PCD: 2026-09-01
Clinical trial
A Randomized, Triple Blinded Cross-over Placebo Controlled Study of Effects of Inhaled Cannabidiol in Healthy Occasional Cannabis UsersStatus: Not yet recruiting, Estimated PCD: 2024-11-01
Clinical trial
Anti-IL4/IL13 Therapy With Dupilumab for Prevention of Refractory Chronic Rhinosinusitis After Endoscopic Sinus Surgery for CRSwNPStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Clinical trial
Brivaracetam: a Prospective and Multicentre Post-marketing Observational StudyStatus: Completed, Estimated PCD: 2022-12-01
Clinical trial
Effectiveness of Pericapsular Nerve Group (PENG) Block Combined to Lateral Femoral Cutaneous Nerve (LFCN) Block on the Quality of Recovery After Total Hip ReplacementStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Continuation of an Open-label, Multi-center Study to Assess Long Term Safety in Canadian Patients With Endogenous Cushing's Syndrome Who Have Completed Prior Recordati-sponsored Osilodrostat (LCI699) Study LCI699C2X01B and Are Judged by the Investigator to Benefit From Continued Treatment With OsilodrostatStatus: Active (not recruiting), Estimated PCD: 2025-11-24
Clinical trial
The Efficacy of Intra-articular Triamcinolone Acetonide 5mg vs. 10 mg vs. 40 mg in Patients With Knee Osteoarthritis: a Non-inferiority Randomized Controlled Double-blind StudyStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Modulation of ∆9-tetrahydrocannabinol Acute Psychoactive Effects by Ranging Doses of Cannabidiol in Healthy, Occasional Cannabis Users: a Controlled, Triple Blind, Randomized, Cross-over StudyStatus: Not yet recruiting, Estimated PCD: 2025-07-31
Clinical trial
Topical Infliximab for the Treatment of Sterile Corneal MeltStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Identifying Predictors Of Long-Lasting Response To Mepolizumab In CRSwNP: Is The Disease-Modifying Role Secondary To Restored Anti-Viral Activity Or Enhanced Epithelial Regeneration?Status: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
Randomized Double-Blind Placebo-Controlled Clinical Trial to Assess the Efficacy of Mycophenolate Mofetil in Subclinical Interstitial Lung Disease Associated With Systemic Sclerosis: a Feasibility StudyStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Clinical trial
Intra-arterial Thrombectomy as an Acute Treatment Intervention for Stoke: the Endovascular Acute Stoke Intervention (EASI) TrialStatus: , Estimated PCD: 2025-01-01
Clinical trial
Prospective Study on the Role of Intravenous Unfractionated Heparin Following Digital Replantation and RevascularizationStatus: Recruiting, Estimated PCD: 2024-09-24
Clinical trial
Efficacy of Cannabinoids to the Current Standard Treatments on Symptom Relief in Persons With Multiple Sclerosis: Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-03-15
Clinical trial
Phase I Trial of Camu Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-Small Cell Lung Cancer and MelanomaStatus: Recruiting, Estimated PCD: 2024-04-15
Clinical trial
Sûreté de la Perfusion Myocardique Par la Tomographie d'émission Par Positron Avec l'Ammoniaque marqué au N-13 du Centre de Recherche du Centre Hospitalier de l'Université de MontréalStatus: Recruiting, Estimated PCD: 2028-01-01
Clinical trial
A Triple-blind, Placebo-controlled, Randomized, Crossover Study of Low Dose Oral Synthetic Cannabidiol Effects in Healthy Cannabis Occasional UsersStatus: Completed, Estimated PCD: 2023-11-14
Clinical trial
Topical Infliximab in Eyes With Penetrating KeratoplastyStatus: Recruiting, Estimated PCD: 2027-03-01
Clinical trial
Phase II Trial of Fecal Microbial Transplantation in Patients With Advanced Non-Small Cell Lung Cancer and Melanoma Treated With Immune Checkpoint Inhibitors.Status: Active (not recruiting), Estimated PCD: 2024-09-01
Clinical trial
A Phase II, Multi-centre Study, of Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases From Non-small Cell Lung Cancer and Renal Cell CancerStatus: Active (not recruiting), Estimated PCD: 2021-01-31
Clinical trial
A Multi-centre, Prospective, Randomized, Open-label, Blinded Endpoint (PROBE) Controlled Trial Comparing Cervical Internal Carotid Artery Stenting to no Stenting During Thrombectomy for Tandem Occlusion StrokeStatus: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
Lung Cancer Cryo-Activation as a Novel Approach to Improve Cancer Immunogenicity and Augment Immunotherapy EfficacyStatus: Completed, Estimated PCD: 2023-06-27
Clinical trial
Choline-PET: Exploratory Study Assessing the Potential Role of F-choline PET Imaging in New and Emerging IndicationsStatus: Recruiting, Estimated PCD: 2032-07-01
Clinical trial
Safety of Topical Insulin Eye Drops for the Treatment of Open-angle GlaucomaStatus: Recruiting, Estimated PCD: 2024-07-01
Abstract
A phase II study of durvalumab re-treatment +/- prednisone in patients who discontinued prior checkpoint therapy due to immune related toxicity (CCTG IND.238A).Org: Juravinski Cancer Inst, BCCA, Sindi Ahluwalia Hawkins Centre for the Southern Interior, Princess Margaret - University Health Network, Juravinski Cancer Centre, McMaster University,
Abstract
Phase I/II trial of durvalumab plus tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma: Final results.Org: Centre hospitalier de l'Université de Montréal, Cross Cancer Institute, London Health Science Centre, Division of Medical Oncology, London Health Sciences Centre & Western University, Jewish General Hospital, Lady Davis Institute, McGill University,
Abstract
Plasma arginine as a candidate predictive biomarker for response to immune checkpoint inhibition (ICI) in metastatic colorectal cancer (mCRC): Analysis of the CCTG CO.26 trial.Org: University Health Network, BCCA Vancouver Cancer Centre, The Ottawa Hospital Cancer Centre, Providence Cancer Institute, Queen's University, Belfast,
Abstract
CCTG EN10: A phase II study of tailored adjuvant therapy in POLE-mutated and p53-wildtype/NSMP early-stage endometrial cancer (EC)—RAINBO BLUE and TAPER.Org: BCCA, Princess Margaret - University Health Network, Saskatchewan Health Authority, Centre hospitalier de l'Université de Montréal, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada,
Abstract
Use of positron emission tomography-computed tomography (PET-CT) scan in cancer patients: A single Canadian academic oncology center experience.Org: Centre Hospitalier Régional de Lanaudière, Université de Montreal, Centre hospitalier de l'Université de Montréal, Centre Hospitalier de l'Université de Montréal (CHUM)-Notre Dame,
Abstract
ANAKINRA IN THE TREATMENT OF ADULT-ONSET STILL'S DISEASEOrg: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Centre hospitalier de l'Université de Montréal, Montreal Institute for Clinical Evaluative Sciences, St Joseph's Health Care, Hamilton Health Sciences,
Clinical trial
Phase I/II of Durvalumab (MEDI4736) + Tremelimumab + Stereotactic Body Radiotherapy for Metastatic Head and Neck CarcinomaStatus: Active (not recruiting), Estimated PCD: 2024-07-31